Tower Research Capital (TRC)’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.19K Sell
82
-3,655
-98% -$261K ﹤0.01% 4074
2025
Q4
$231K Buy
3,737
+3,723
+26,593% +$219K 0.01% 1337
2025
Q3
$822 Sell
14
-11,705
-100% -$682K ﹤0.01% 4935
2025
Q2
$683K Sell
11,719
-26,197
-69% -$1.48M 0.02% 747
2025
Q1
$1.88M Buy
37,916
+36,068
+1,952% +$1.85M 0.06% 303
2024
Q4
$82.7K Sell
1,848
-2,428
-57% -$115K ﹤0.01% 2260
2024
Q3
$206K Buy
4,276
+2,282
+114% +$110K 0.01% 1598
2024
Q2
$102K Sell
1,994
-15,767
-89% -$863K ﹤0.01% 2569
2024
Q1
$965K Sell
17,761
-13,908
-44% -$725K 0.02% 535
2023
Q4
$1.78M Buy
31,669
+30,534
+2,690% +$1.73M 0.02% 551
2023
Q3
$70.1K Buy
+1,135
New +$71.8K ﹤0.01% 2260
2023
Q2
Sell
-35
Closed -$3K 6269
2023
Q1
$3K Sell
35
-2,607
-99% -$201K ﹤0.01% 5218
2022
Q4
$193K Sell
2,642
-773
-23% -$61.1K 0.01% 1322
2022
Q3
$285K Sell
3,415
-38,432
-92% -$3.31M ﹤0.01% 1595
2022
Q2
$3.33M Buy
41,847
+11,735
+39% +$1.14M 0.07% 218
2022
Q1
$3.12M Buy
30,112
+25,991
+631% +$2.15M 0.03% 449
2021
Q4
$308K Buy
4,121
+3,951
+2,324% +$277K 0.01% 1462
2021
Q3
$11K Sell
170
-3,623
-96% -$221K ﹤0.01% 4239
2021
Q2
$230K Sell
3,793
-6,322
-63% -$374K 0.01% 1812
2021
Q1
$543K Buy
10,115
+2,803
+38% +$152K 0.01% 1176
2020
Q4
$351K Buy
7,312
+6,473
+772% +$286K 0.01% 1276
2020
Q3
$33K Sell
839
-28,005
-97% -$1.02M ﹤0.01% 3696
2020
Q2
$927K Buy
28,844
+28,734
+26,122% +$1,000K 0.04% 573
2020
Q1
$4K Sell
110
-3,506
-97% -$140K ﹤0.01% 2381
2019
Q4
$173K Sell
3,616
-28,524
-89% -$1.38M 0.01% 649
2019
Q3
$1.6M Buy
32,140
+28,001
+677% +$1.43M 0.11% 159
2019
Q2
$222K Sell
4,139
-990
-19% -$51.7K 0.02% 824
2019
Q1
$271K Buy
5,129
+3,582
+232% +$187K 0.02% 996
2018
Q4
$73K Buy
1,547
+247
+19% +$12.9K 0.01% 1098
2018
Q3
$75K Sell
1,300
-15,316
-92% -$848K 0.01% 1515
2018
Q2
$905K Buy
16,616
+6,170
+59% +$306K 0.05% 383
2018
Q1
$494K Buy
+10,446
New +$523K 0.04% 478

Other funds holding NTR

Tower Research Capital (TRC)'s NTR Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Nutrien (NTR) stake by 98% in Q1 2026, selling an estimated $261K and leaving 82 shares worth $6.19K. The position accounts for ﹤0.01% of the portfolio, ranked #4074.

Tower Research Capital (TRC) first reported a position in NTR in Q1 2018 and has held it in 32 quarters since. The position peaked at $3.33M in Q2 2022. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • Tower Research Capital (TRC) held 82 shares of Nutrien worth $6.19K as of Q1 2026.
  • Tower Research Capital (TRC) sold 3,655 Nutrien shares in Q1 2026, an estimated $261K.
  • Nutrien made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4074 holding.
  • Tower Research Capital (TRC) first reported a position in Nutrien in Q1 2018 and has held it in 32 quarters since.
  • Tower Research Capital (TRC)'s Nutrien position peaked at $3.33M in Q2 2022.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.